Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Process for preparation of dinapsoline

An independent, compound technology, applied in the field of dinaporine and some derivatives, can solve problems such as unreproducible yields and problems with cyclization steps

Inactive Publication Date: 2004-02-04
PURDUE RES FOUND INC
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The cyclization step near the end of the synthesis was found to be problematic and if any product was formed the yields were not reproducible at all

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Process for preparation of dinapsoline

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0007] The present invention relates to a new method for preparing denatoprine and its derivatives for treating motor diseases and having the following structure, where R 1 and R 2 each independently is hydrogen or a hydroxyl protecting group; or R 1 and R 2 can be linked together to form -(CH 2 ) n -; n is 1-3; A is CH 2 、CHOR 1 or C=O; and R 4 , R 5 and R 6 each independently hydrogen, C 1-4 Alkyl, C 1-4 Alkoxy, hydroxy or halogen. This new and improved method is exemplified in Reaction Scheme 4.

[0008] The present invention also provides certain denapoline derivatives of formula IX for use in the treatment of motor disorders.

[0009] As used herein and in the claims (unless the context dictates otherwise), the term "C 1-4 "Alkyl" refers to straight chain or branched chain alkyl such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl and tert-butyl. As used herein and in the claims, the term "C 1-4 "Alkoxy" means a straight or branched chain alkoxy group...

Embodiment 15

[0042] Embodiment 15-bromoisoquinoline

[0043] The experimental setup consisted of a 500ml three-neck flask equipped with a condenser, a dropping funnel, and a stirrer terminated in a rigid crescent-shaped Teflon polytetrafluoroethylene slurry. AlCl was added to a flask containing isoquinoline (57.6 g, 447 mmol) 3 (123g, 920mmol). The mixture was heated to 75-85°C. Bromine (48.0 g, 300 ml) was added dropwise over a period of 4 hours using a dropping funnel. The resulting mixture was stirred at 75°C for 1 hour. Pour the almost black mixture over crushed ice and stir well by hand. The cooled mixture was treated with aqueous sodium hydroxide (10N) to dissolve all aluminum salts as sodium aluminate and the oil layer was extracted with ether. use Na 2 SO 4 After drying and concentration, the ether extract was distilled at 0.3 mm. A white solid (16.3 g, 78 mmol) was obtained from the fraction at about 125°C (26% yield). The product was further purified...

Embodiment 25

[0050] Embodiment 25-isoquinoline formaldehyde (isoquinolinecarboxaldehyde)

[0051] At -78°C, add bromoisoquinoline (5.0 g, 24 mmol) in THF dropwise to n-butyllithium (19.3 ml 2.5 M n-hexane solution, 48 mmol) in ether (80 ml) and THF (80 ml) mixture solution (10ml) solution. The reaction mixture was heated at -78°C for 30 minutes. A solution of DMF (3.30 g, 45 mmol) in THF (10 ml) was cooled to -78 ℃ and quickly added to the lithium isoquinolate solution. The mixture was stirred at -78°C for 15 minutes. Ethanol (20ml) was added followed by NH 4 Cl solution. The suspension was warmed to room temperature. The organic layer combined with the ether extract was washed with Na 2 SO 4 dry. Pale yellow solid (2.4 g, 15 mmol, 64% yield) was obtained by chromatography (SiO 2 Type-H, 50% EtOAc / hexane) and recrystallized (ethanol): mp 114-116 °C;

[0052] 1 H NMR (DMSO-d 6 )δ10.40(s, 1H), 9.44(s, 1H), 8.85(d, 1H, J=6.0Hz),

[0053] 8.69(d, 1H, J=6.0H...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a novel process for the preparation of compounds of the formulawherein R[1], R[2], R[4], R[5], R[6]and A are as defined herein, and to certain derivations of Formula IX which are useful for the treatment of movement disorders.

Description

technical field [0001] The present invention relates to a process for the preparation of dinapsoline and certain derivatives thereof useful as dopamine receptor agonists in the treatment of movement disorders. Background technique [0002] Dopamine has been implicated in many neurological diseases. It is generally recognized that excess or deficiency of functional dopaminergic activity in the central and / or peripheral nervous system can cause hypertension, narcolepsy and other behavioral, neurological, physiological and motor disorders including Parkinson's disease, weakness A chronic progressive disorder characterized by the control of the voluntary motor system. [0003] International Patent WO 97 / 06799, published February 27, 1997, describes a number of ligands useful in the treatment of dopamine-related central and peripheral nervous system dysfunction, which have the tetrahydro-1H-naphthalene described below [ 1,2,3-de]isoquinoline general chem...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/473A61K31/4741A61P25/00A61P25/16A61P43/00C07D221/18C07D491/056C07D491/06
CPCC07D491/06C07D221/18Y02P20/55A61P25/00A61P25/14A61P25/16A61P43/00
Inventor S·-Y·薛S·E·亚库廷-波尔特
Owner PURDUE RES FOUND INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products